• Skip to main content

DistilNFO Health

Health Sector News from India

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

One COVID-19 vaccine enter phase-3 human trial: Health Ministry

Share:

August 20, 2020

The Ministry of Health and Family Welfare said on Tuesday that one of the three COVID-19 vaccine candidates would enter the third phase of the pre-clinical human trial by Wednesday.

The information was shared by Dr VK Paul, head of the national task force on COVID-19, during a weekly press briefing.

The ministry officials said that the vaccine candidate entering the third phase has yielded encouraging results in the initial phases of its trial. Paul added that the other two vaccines are currently in phase-I or II of their pre-clinical trials. However, they did not reveal the names of the vaccines while sharing the status of their testing phase.

While the officials did not reveal the names of the vaccine candidates while speaking about their testing phase, it could be gathered that the vaccine entering the third phase is Bharat Biotech’s Covaxin, jointly developed with the Indian Council of Medical Research (ICMR).

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

India has currently three vaccine candidates for COVID-19.

ChAdOx1, developed by Oxford University and manufactured jointly by the Serum Institute of India (SII), Pune and AstraZeneca, Bharat Biotech’s Covaxin, jointly developed with the Indian Council of Medical Research and the third is ZycovD by Zydus Cadila.

The SII stated on Monday that it would start phase-2 trial of its COVID-19 vaccine this week. It added that it has shortlisted 10 centres across India to host phases-2 and 3 for human clinical trials. Meanwhile, Zydus Cadila administered the second dose of its COVID-19 vaccine a few days ago.

The developments on the vaccine came a day after the National Expert Group on Vaccine Administration met five domestic COVID vaccine manufacturers to review the clinical trial stages of these vaccine candidates. The manufacturers included two whose products are not yet in the clinical trial stage in India.

Zydus Cadila had stated in the review meeting that it may be able to launch the vaccine by next year.

Source: Indileak

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

Related Posts

  • Clinical Evidence is the Mainstay of Decision-Making in the Choice of Stents : Dr Samuel MathewClinical Evidence is the Mainstay of Decision-Making in the Choice of Stents : Dr Samuel Mathew
  • Government Bans Export of 26 Pharma IngredientsGovernment Bans Export of 26 Pharma Ingredients
  • Medical Diplomacy: India Extends a Helping Hand to African NationsMedical Diplomacy: India Extends a Helping Hand to African Nations
  • Indian Health Service Expands Telehealth During the CoronavirusIndian Health Service Expands Telehealth During the Coronavirus
  • Reliance Buys Majority Stake in Online Pharmacy Netmeds for $83 MillionReliance Buys Majority Stake in Online Pharmacy Netmeds for $83 Million
  • Patients Seek Transparency in Hosp Expenses Under Health Schemes
  • Can the Draft Policy 2020 Help Build a Strong Senior Care Ecosystem in India?
  • India’s Health Tourism Sector to Revive Faster Than PeersIndia’s Health Tourism Sector to Revive Faster Than Peers

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications